Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    October 2018
  1. CRESTANELLO JA, Daly RC
    The Surgical Treatment for Ischemic Heart Failure trial: A landmark study.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32839.
    PubMed     Text format    


    September 2018
  2. HANNAN EL, Samadashvili Z, Smith CR, Lahey SJ, et al
    Mitral valve repair versus replacement for patients with preserved left ventricular function without heart failure symptoms.
    J Thorac Cardiovasc Surg. 2018 Sep 26. pii: S0022-5223(18)32485.
    PubMed     Text format     Abstract available


  3. MICHLER RE
    A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned.
    J Thorac Cardiovasc Surg. 2018 Sep 22. pii: S0022-5223(18)32356.
    PubMed     Text format    


    June 2018
  4. IRIBARNE A, DiScipio AW, Leavitt BJ, Baribeau YR, et al
    Comparative effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in a real-world Surgical Treatment for Ischemic Heart Failure trial population.
    J Thorac Cardiovasc Surg. 2018 Jun 1. pii: S0022-5223(18)31458.
    PubMed     Text format     Abstract available


    April 2018
  5. ZENATI MA, Bhatt DL
    Real-world revascularization therapy in heart failure: It's a jungle out there!
    J Thorac Cardiovasc Surg. 2018 Apr 24. pii: S0022-5223(18)31207.
    PubMed     Text format    


    February 2018
  6. HAN JJ, Atluri P
    Think beyond the cell: Can we [tissue] engineer a solution to heart failure?
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30350.
    PubMed     Text format    


  7. NGUYEN LS, Baudinaud P, Brusset A, Nicot F, et al
    Heart failure with preserved ejection fraction as an independent risk factor of mortality after cardiothoracic surgery.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30363.
    PubMed     Text format     Abstract available


    January 2018
  8. LEE TM
    Does nature provide the clues for future heart failure treatments?
    J Thorac Cardiovasc Surg. 2018 Jan 5. pii: S0022-5223(18)30016.
    PubMed     Text format    


  9. CARRIER M
    Patient selection is the key issue in the surgical treatment of patients with end-stage heart failure.
    J Thorac Cardiovasc Surg. 2018;155:235.
    PubMed     Text format    


  10. ADHYAPAK SM, Parachuri VR
    High-risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure: A seemingly viable option.
    J Thorac Cardiovasc Surg. 2018;155:233.
    PubMed     Text format    


    December 2017
  11. CARROZZINI M, Toto F, Gerosa G, Bottio T, et al
    Irreversible cardiac failure with intraventricular thrombosis: A novel technique of paracorporeal biventricular assist device implantation with ventricles excision.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32845.
    PubMed     Text format    


    June 2017
  12. DELLIS SL, Pennel T, Said-Hartley Q, Zilla P, et al
    Sinus of Valsalva-right atrial tunnel causing heart failure in a 38-year-old.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31172.
    PubMed     Text format    


  13. DAVIES RR
    Heading toward the future of pediatric heart failure with continuous-flow ventricular assist devices.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31167.
    PubMed     Text format    


    March 2017
  14. KAWAJIRI H, Manlhiot C, Ross H, Delgado D, et al
    High-risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure.
    J Thorac Cardiovasc Surg. 2017 Mar 21. pii: S0022-5223(17)30544.
    PubMed     Text format     Abstract available


    February 2017
  15. HOEFER J, Ulmer H, Kilo J, Margreiter R, et al
    Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2017 Feb 9. pii: S0022-5223(17)30203.
    PubMed     Text format     Abstract available


    December 2016
  16. CANVER CC
    Video-assisted thoracoscopic bilateral thoracic sympathectomy: An alternative to pharmaceutical disruption of sympathetic neural activity in patients with heart failure.
    J Thorac Cardiovasc Surg. 2016 Dec 12. pii: S0022-5223(16)31651.
    PubMed     Text format    


    July 2016
  17. GROSMAN-RIMON L, Rao V
    Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic targets.
    J Thorac Cardiovasc Surg. 2016;152:290.
    PubMed     Text format    


  18. SPILIOPOULOS S, Koerfer R, Tenderich G
    Occult bleeding in left ventricular assist device recipients: It is the patient rather than the pump.
    J Thorac Cardiovasc Surg. 2016;152:289-90.
    PubMed     Text format    


  19. SQUIERS JJ, Lima B, DiMaio JM
    Contemporary extracorporeal membrane oxygenation therapy in adults: Fundamental principles and systematic review of the evidence.
    J Thorac Cardiovasc Surg. 2016;152:20-32.
    PubMed     Text format     Abstract available


  20. GAFFEY AC, Doll SL, Thomasson AM, Venkataraman C, et al
    Transplantation of "high-risk" donor hearts: Implications for infection.
    J Thorac Cardiovasc Surg. 2016;152:213-20.
    PubMed     Text format     Abstract available



  21. Discussion.
    J Thorac Cardiovasc Surg. 2016;152:218-20.
    PubMed     Text format    


    June 2016
  22. HASEGAWA T, Oshima Y, Tanaka T, Maruo A, et al
    Clinical assessment of diastolic retrograde flow in the descending aorta for high-flow systemic-to-pulmonary artery shunting.
    J Thorac Cardiovasc Surg. 2016;151:1540-6.
    PubMed     Text format     Abstract available


  23. AKHTER SA
    Continuous-flow left ventricular assist devices and bleeding events: Is there a biological role for decreasing pump speed?
    J Thorac Cardiovasc Surg. 2016;151:1755-6.
    PubMed     Text format    


  24. KANG J, Zhang DM, Restle DJ, Kallel F, et al
    Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
    J Thorac Cardiovasc Surg. 2016;151:1747-1754.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: